Bio News
European researchers developed a diagnostic method that uses the blood test-based BioTAK score to distinguish takotsubo syndrome (TTS) from acute coronary syndrome (ACS). The score combines four biomarkers and sex and achieved an accuracy of 0.97 in the development cohort. The researchers said the score could provide a presumptive diagnosis for about 90% of patients before coronary angiography.
Biobook Team
biobookmedia@biobook.co.krBrazilian Health Regulatory Agency Approves Gazyva for a New Indication in Systemic Lupus Erythematosus
Belgium’s Amadcell acquires two Lakefront CAR T therapies for up to $230 million
OrbiMed Raises $3 Billion, Its Largest Asia Fund to Date
UK Researchers Identify New Mechanism of Antifungal Drug Resistance in Candida auris
AstraZeneca Signs $1.5 Billion AI Drug Target Discovery Deal With Insitro
Hyundai Pharmaceutical’s Third-Quarter Operating Profit Reaches KRW 5.937 Billion, Up 44% Year Over Year
